The Los Angeles Latino Eye Study:☆
design, methods, and baseline data
Abstract
Objective
To describe the study design, operational strategies, procedures, and baseline characteristics of the Los Angeles Latino Eye Study (LALES), a population-based assessment of the prevalence of visual impairment, ocular disease, and visual functioning in Latinos.
Design
Population-based, cross-sectional study.
Participants
Six thousand three hundred fifty-seven Latinos 40 years and older from 6 census tracts in Los Angeles, California.
Methods
A detailed interview and eye examination were performed on each eligible participant. The interview included an assessment of demographic, behavioral, and ocular risk factors and health-related and vision-related quality of life. The eye examination included a measurement of visual acuity, intraocular pressure, and visual fields; fundus and optic disc photography; a detailed anterior and posterior segment examination; and measurement of blood pressure, glycosylated hemoglobin levels, and blood glucose levels.
Main outcome measures
Prevalence of visual impairment, blindness, cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration constitute the study's primary outcome variables. Secondary outcomes include odds ratios for risk factors associated with eye disease, health-related quality of life, and vision-related quality of life. Response rates and baseline characteristics are presented.
Results
Of the 7789 individuals eligible for LALES, 6357 (82%) had a clinical examination; an additional 524 completed only an in-home interview. The majority of participants were female (58%), the average (± standard deviation) age was 54.9 (±10.8) years, and 80.0% were of Mexican origin and 0.4% self-identified as American Indian or Alaskan Native. The age distribution of LALES participants was similar to that of Latinos of Mexican origin in the rest of the United States.
Conclusion
The LALES has recruited Latinos 40 and older for an ophthalmic epidemiologic study. The LALES cohort will provide information about the prevalence and risk factors of ocular disease in the largest and fastest growing minority in the United States.
To access this article, please choose from the options below
☆ This work was supported by the National Eye Institute, Bethesda, Maryland (grant nos.: EY11753 and EY03040); the National Center on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland; and an unrestricted grant from Research to Prevent Blindness, New York, New York. Dr Varma is a Research to Prevent Blindness Sybil B. Harrington Scholar.The authors have no proprietary or commercial interest in any materials discussed in the article.
PII: S0161-6420(04)00291-X
doi:10.1016/j.ophtha.2004.02.001
© 2004 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

